FT
JAZZ icon

Fiduciary Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fiduciary Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.61M Sell
8,541
-2,688
-24% -$470K 0.02% 320
2025
Q4 		$1.91M Sell
11,229
-1,185
-10% -$182K 0.02% 289
2025
Q3 		$1.64M Sell
12,414
-1,097
-8% -$132K 0.02% 318
2025
Q2 		$1.43M Sell
13,511
-29,934
-69% -$3.25M 0.02% 332
2025
Q1 		$5.39M Buy
43,445
+37,059
+580% +$4.83M 0.07% 158
2024
Q4 		$786K Sell
6,386
-384
-6% -$45.3K 0.01% 400
2024
Q3 		$754K Buy
6,770
+2,246
+50% +$246K 0.01% 408
2024
Q2 		$483K Buy
4,524
+1,481
+49% +$163K 0.01% 456
2024
Q1 		$366K Buy
+3,043
New +$373K 0.01% 520

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fiduciary Trust's JAZZ Position: Q1 2026 in Review

Fiduciary Trust reduced its Jazz Pharmaceuticals (JAZZ) stake by 24% in Q1 2026, selling an estimated $470K and leaving 8,541 shares worth $1.61M. The position accounts for 0.02% of the portfolio, ranked #320.

Fiduciary Trust first reported a position in JAZZ in Q1 2024 and has held it in 9 quarters since. The position peaked at $5.39M in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Fiduciary Trust held 8,541 shares of Jazz Pharmaceuticals worth $1.61M as of Q1 2026.
  • Fiduciary Trust sold 2,688 Jazz Pharmaceuticals shares in Q1 2026, an estimated $470K.
  • Jazz Pharmaceuticals made up 0.02% of Fiduciary Trust's portfolio in Q1 2026, its #320 holding.
  • Fiduciary Trust first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Fiduciary Trust's Jazz Pharmaceuticals position peaked at $5.39M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.